M11.169 Familial chondrocalcinosis, unspecified knee

Name of the Condition

• Familial chondrocalcinosis, unspecified knee

Summary

Familial chondrocalcinosis, unspecified knee is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the knee joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and knee-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, unspecified knee is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the knee’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Knee trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Knee pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion.
• Joint locking or instability.
• Warmth or redness in the knee area.

Diagnosis

Diagnosis of familial chondrocalcinosis, unspecified knee involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI), and laboratory tests. Joint fluid analysis may be performed to identify CPPD crystals under polarized light microscopy. Imaging often reveals chondrocalcinosis (calcium deposits) in the knee joint. Genetic testing may be considered if a hereditary pattern is suspected, though it is not always required for diagnosis.

Treatment Options

Treatment focuses on managing symptoms and preventing joint damage. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may reduce inflammation and pain during acute episodes. Intra-articular corticosteroid injections can provide targeted relief. Physical therapy helps maintain joint function and mobility. For chronic cases, disease-modifying therapies or surgical intervention (e.g., joint lavage or arthroscopy) may be considered. Lifestyle modifications, such as weight management and activity modification, support joint health.

Prognosis and Follow-Up

The prognosis varies depending on the severity of crystal deposition and joint damage. Early diagnosis and treatment can help manage symptoms and slow progression. Recurrent flare-ups are common, and long-term joint damage may occur in some cases. Regular follow-up with a healthcare provider is recommended to monitor joint function, adjust treatment, and address complications. Imaging and clinical evaluations may be repeated to assess disease progression.

Complications

• Chronic joint pain and stiffness.
• Progressive cartilage damage or osteoarthritis.
• Joint deformity or instability.
• Reduced mobility and functional impairment.
• Increased risk of falls due to knee instability.

Lifestyle & Prevention

• Maintain a healthy weight to reduce knee stress.
• Engage in low-impact exercises (e.g., swimming, cycling) to preserve joint function.
• Avoid activities that strain the knee (e.g., heavy lifting, high-impact sports).
• Manage metabolic conditions (e.g., hyperparathyroidism) that may contribute to crystal formation.
• Follow prescribed treatment plans to minimize flare-ups.

When to Seek Professional Help

Seek medical attention if you experience:

• Sudden, severe knee pain or swelling.
• Inability to bear weight on the knee.
• Persistent stiffness or reduced range of motion.
• Signs of infection (e.g., fever, redness, warmth).
• Worsening symptoms despite home care or prescribed treatment.

Tips for Medical Coders

When coding for familial chondrocalcinosis, unspecified knee (M11.169), ensure documentation supports the hereditary nature of the condition and its involvement of the knee joint. Note the absence of specification for left or right knee, as the code is for an unspecified site. Verify that clinical details align with the diagnosis, including symptoms, imaging findings, or crystal identification, to confirm accurate code assignment. Avoid using this code if the knee involvement is specified (e.g., left or right) or if the condition is non-familial.